Reported 3 days ago
In the context of significant weight-loss drugs like Ozempic and Wegovy, opinions among top advisers within President-elect Donald Trump's circle are sharply divided. Elon Musk advocates for their wider availability, while Robert F. Kennedy Jr. criticizes the drugs as overpriced. Dr. Mehmet Oz, who has promoted these drugs on his show, aligns with Musk in supporting their potential. A crucial debate revolves around whether Medicare will cover these medications, with federal spending implications that could affect millions and reshape obesity treatment options.
Source: YAHOO